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Abstract
Background:  The regulation of programmed cell death is critical to developmental homeostasis
and normal morphogenesis of embryonic tissues. Survivin, a member of the inhibitors of apoptosis
protein (IAP) family primarily expressed in embryonic cells, is both an anti-apoptosis and a pro-
survival factor. Since our previous studies have demonstrated the importance of apoptosis during
embryonic submandibular salivary gland (SMG) development, we postulated that survivin is a likely
mediator of SMG epithelial cell survival.
Results:  We investigated the developmental expression of survivin in Pseudoglandular (~ E14),
Canalicular (~ E15) and Terminal Bud (~ E17) Stage SMGs. We report a significant 26% increase in
transcript levels between the Canalicular and Terminal Bud Stages. Immunohistochemical studies
demonstrate  nuclear-localized  survivin  protein  in  epithelial  cells  bounding  forming  lumina  in
Canalicular and Terminal Bud Stage SMGs.
Conclusions:  Survivin is known to be a pro-survival and anti-apoptotic factor. Given that survivin
translocation into the nucleus is required for the induction of entry into the cell cycle and the
inhibition of apoptosis, our demonstration of nuclear-localized survivin protein in presumptive
d u c t a l  a n d  p r o a c i n a r  l u m e n -b o u n d i n g  c e l l s  s u g g e s t s  t h a t  s u r v i v i n  m a y  b e  a  k e y  m e d i a t o r  o f
embryonic SMG epithelial cell survival.
Introduction
Embryonic submandibular gland (SMG) development is
best conceptualized in stages rather than gestational age
[1]. Repeated branching at the distal ends of the initial
epithelial SMG bud produces a bush-like structure con-
sisting of a network of elongated epithelial branches with
epithelial buds at their termini by the Pseudoglandular
Stage. In the Canalicular Stage, the number of epithelial
lobes has increased and the presumptive ducts begin to
exhibit distinct lumina. By the Terminal Bud Stage,
these branches and buds are hollowed out to form the
presumptive ducts and acini. Our prior studies have in-
dicated that lumen formation is initiated in the Canalic-
ular Stage with the death of the central cells, with each
consecutive concentric layer of cells dying until only a
single layer of epithelial cells surrounds the lumina [1, 2].
The demonstration of p53 concentrated to and marking
the next concentric layer of epithelial cells destined for
death suggests that p53/caspase3-mediated apoptosis is
important to terminal bud lumen formation [2, 3]. By
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contrast, caspase8/caspase3-mediated apoptosis is im-
portant to ductal lumen formation [3]. However, al-
though we have identified different apoptotic pathways
which mediate duct and terminal bud lumen formation,
little is known about which molecule(s) mediate the ap-
optotic stop signal such that these lumen-bounding epi-
thelial cells survive.
The regulation of programmed cell death is critical to de-
velopmental homeostasis and normal morphogenesis of
embryonic tissues. Survivin, a member of the inhibitors
of apoptosis protein (IAP) family, is unique in that it is
prominently expressed in embryonic tissues, overex-
pressed in cancer cells, and relatively undetectable in
normal adult tissues [4– 7]. Gene targeting experiments
indicate that survivin is both a pro-survival and an anti-
apoptotic factor [5, 8]. Survivin has also been shown to
be essential for mitosis during development since null
embryos exhibit disrupted microtubule formation, be-
come polyploid, and fail to survive beyond day 4.5 [9].
Survivin, expressed in a cell cycle dependent manner [9,
10], has been shown in cell lines to translocate into the
nucleus where it competitively binds to Cdk4/p16INK4a
[11]. The resultant Cdk4/survivin complex directly or in-
directly activates Cdk2/Cyclin E for S phase entry [11].
The survivin/Cdk4 complex formation also causes the
release of p21 which translocates to mitochondria to
form a complex with procaspase 3, which inhibits cell
death [12].
Given the above, we postulated that survivin is an impor-
tant pro-survival and anti-apoptotic molecule during
embryonic ductal and proacinar formation. In this pa-
per, we investigated the developmental expression of
survivin transcripts and protein in embryonic SMGs.
This is the first report of notable developmental changes
in survivin expression and protein localization correlat-
ed with embryonic lumen formation.
Results and Discussion
Expression of Survivin Transcript
To elucidate a potential role for survivin during embry-
onic SMG morphogenesis, we evaluated survivin tran-
script levels in Pseudoglandular (~ E14), Canalicular (~
E15) and Terminal Bud (~ E17) Stage SMGs using primer
extension analysis. As shown in Figure 1, survivin tran-
scripts were detected in all stages investigated. There
was no significant change in survivin mRNA levels be-
tween the Pseudoglandular and Canalicular Stages. By
contrast, there was a significant ~ 26% increase (p <
0.05) in survivin transcript levels between the Canalicu-
lar and Terminal Bud Stages, this significant increase
being concomitant with extensive epithelial cell apopto-
sis which results in lumina formation [1].
Determination of Antibody Specificity
Prior to determining the cell-specific distribution of sur-
vivin protein during embryonic SMG development, the
specificity of the anti-survivin antibody was evaluated by
determining its reactivity on Western blots of lysates of 3
cancer cell lines (MO7E, HL-60, and HELA) since cancer
cell lines have been shown to overexpress survivin pro-
tein [5, 6]. Using the unpurified anti-survivin antiserum,
survivin protein (Mr ~ 16 kDa) was detected in all cell
lines but not in normal whole human blood cell lysates
(Fig. 2); survivin was not detected by the control serum.
After affinity purification, a single ~ 16 kDa band was de-
tected in HL-60 human cells (Fig. 3) using this antibody;
no band was seen in the affinity column eluate of the pre-
immune serum. Our affinity-purified antibody was then
evaluated for its ability to localize survivin protein in tis-
sue sections. Our observation of survivin immunolocali-
zation in pulmonary epithelia (data not shown) is
identical to that previously reported [4]. Based on the
above results, we conclude that this anti-survivin anti-
body is specific for survivin protein.
Figure 1
Quantitative  analysis  of  survivin  trancript  levels  during
embryonic SMG development. Inset. Primer extension analy-
sis of Pseudoglandular (Ps), Canalicular (Ca) and Terminal Bud
(TB) Stage SMGs. The relative level of survivin transcript is
presented as the percent transcript level relative to that in
Pseudoglandular Stage SMGs.BMC Developmental Biology (2001) 1:5 http://www.biomedcentral.com/1471-213X/1/5
Spatiotemporal Distribution of Survivin
We then evaluated the pattern of survivin immunolocal-
ization in embryonic SMGs with progressive develop-
ment. In the Pseudoglandular Stage, survivin protein is
diffusely distributed throughout the cytoplasm of
branching epithelia and is absent from the mesenchyme
(Fig. 4A). This cytoplasmic distribution of survivin pro-
tein suggests that survivin may not have translocated
into the nucleus to form a survivin/Cdk4 complex at this
early developmental stage. In the Canalicular Stage, epi-
thelial cell apoptosis toward the center of presumptive
ducts results in initial ductal lumen formation [1]. At the
sites of lumen formation, intense survivin staining is
seen in nuclei of the columnar epithelial cells bounding
forming lumina (Fig. 4B). In contrast, those epithelial
cells not surrounding the forming lumen do not display
nuclear-localized survivin protein (Fig. 4B). As develop-
ment progresses through the Terminal Bud Stage, termi-
nal buds hollow out until only a single layer of epithelial
cells surround terminal bud lumina (Fig. 4C) [1]. Nucle-
ar-localized survivin protein is seen in these lumen-
bounding terminal bud epithelial cells destined to sur-
vive (Fig. 4D), as well as in lumen-bounding ductal epi-
thelia (Fig. 4E). Although nuclear translocation of
survivin has been shown to be required for survivin-in-
duced initiation of the cell cycle in cell lines in vitro [11],
this is the first report of survivin translocation into the
nuclei of embryonic cells in vivo. Cell proliferation, but
not apoptosis, is seen in this single layer of terminal bud
epithelial cells which is adjacent to mesenchyme and ex-
tracellular matrix [1]. This observation is consistent with
the previous report that survivin is primarily found in
proliferating cells [6, 8].
Although survivin has previously been demonstrated in
embryonic lung epithelia [4], this is the first report of
qualitative and quantitative changes in survivin expres-
sion in any developing branching organ. Further, it is in-
teresting to note that substantial differences in survivin
protein localization exist between embryonic lungs and
SMGs. Survivin protein is nuclear-localized in late em-
bryonic SMG epithelia surrounding forming lumina (Fig.
4) whereas it remains diffusely distributed, and not nu-
clear-localized, in pulmonary lumen-bounding epithelia
(data not shown). The likely explanation for this notable
difference in these analogous branching organs is the dif-
ferent mechanisms of their lumina formation. The pul-
monary lumen forms as an extension of the tracheal
lumen into the lung bud; repeated branching of the lung
bud results in an extensive epithelial tree which sur-
rounds the pulmonary lumina [13]. Since apoptosis is
not a key factor in pulmonary lumina formation, a pro-
survival/anti-apoptosis signal is not needed for epitheli-
al cell survival and, thus, the survivin pathway is not ac-
tivated. By contrast, the SMG bud develops as a solid
cord of epithelium, with SMG lumina being formed by
the death of central epithelial cells, and subsequently
each consecutive concentric layer of terminal bud epithe-
lial cells, until a single layer of "surviving" epithelial cells
surround the lumina [2]. Thus, molecule(s) mediating an
apoptotic stop signal are required for these lumen-
bounding epithelial cells to survive. Interestingly, Bcl-2
and NFκ B, other pro-survival/anti-apoptosis factors, are
absent from these Terminal Bud stage bud epithelia [3,
14]. Given that survivin translocation into the nucleus is
necessary for Cdk4/survivin complex formation, induc-
tion of cell cycle entry, and inhibition of caspase 3-medi-
ated apoptosis [11, 12, 15], our observation of nuclear-
localized survivin protein in proacinar (Fig. 4D) and duc-
tal epithelia (Fig. 4E) suggests that survivin may be a key
Figure 2
Western blot analysis using whole antiserum shows the pres-
ence of survivin protein in 3 cancer cell lines (MO7E, HL-60,
and  HELA).  Survivin  protein  was  not  detected  in  whole
blood lysates or control preimmune serum.
Figure 3
Western blot analysis for survivin expression. Using affinity-
purified anti-survivin antibody, survivin protein was identified
as a single ~ 16 kDa band in HL-60 lysates. No band was seen
in affinity column eluate of prebleed serum.BMC Developmental Biology (2001) 1:5 http://www.biomedcentral.com/1471-213X/1/5
Figure 4
Spatial distribution of survivin protein during embryonic SMG development. A. Survivin protein is diffusely distributed through-
out the branching epithelia (e) and absent from the mesenchyme (m) in the Pseudoglandular Stage. B. Intense survivin immunos-
tain is seen in ductal columnar epithelial cells which surround forming lumina (arrow heads) in the Canalicular S tage . By
contrast, survivin protein retains its diffuse distribution in terminal bud (t) epithelia lacking lumina and in outer ductal cuboidal
epithelial cells. C-E. Terminal Bud Stage SMGs exhibit distinct lumina in presumptive ducts (d) and acini (a). Note intense immu-
nostain in the inner layer of ductal epithelia and the single layer of terminal bud epithelia which surround distinct lumina . D.
Higher magnification of Terminal Bud Stage SMG exhibiting nuclear localization (arrows) of survivin protein in presumptive acini
cells bounding distinct lumina (*). E. Higher magnification of a Late Terminal Bud Stage ductal epithelial bilayer which consists of
an inner columnar epithelia which surround the distinct lumen and an outer cuboidal epithelia which abuts the basement mem-
brane. Nuclear localization (double arrowheads) of survivin protein is seen in the inner layer of columnar epithelial cells sur-
rounding the lumen (*) and not in the outer cuboidal epithelia. A-C. Bar, 50  µ m. D-E, Bar, 25 µ m.BMC Developmental Biology (2001) 1:5 http://www.biomedcentral.com/1471-213X/1/5
factor for the survival of epithelial cells surrounding
forming ductal and terminal bud lumina.
Finally, it is interesting that extensive cell proliferation,
but not apoptosis, is seen in Initial Bud and Pseudoglan-
dular Stage SMG epithelia in the absence of survivin pro-
tein. To gain insight into which molecules likely protect
these early embryonic SMG cells from apoptosis, we
must turn to recent gene targeting experiments [16, 17]
investigating FGF-10 and its receptor, FGF-R2(IIIb).
Analysis of Fgf10 null and Fgfr2(IIIb) transgenic mice
indicate that FGF10/FGF-R2(IIIb) signal transduction is
essential for SMG branching morphogenesis [16, 17];
SMGs are absent in E14.5 and older mice. However the
presence of an initial SMG epithelial bud which subse-
quently undergoes cell death in the absence of FGF-
R2(IIIb) signaling [16], suggests that FGF10/FGF-R2-
(IIIb) signaling mediates epithelial cell survival during
the  Pseudoglandular Stage. What remains unclear is
which factor or factors protect the initial bud epithelium
from apoptosis. Further studies are needed to address
this question.
Conclusions
Although apoptosis has been shown to mediate embry-
onic SMG ductal and proacinar lumen formation, little is
known about which factor(s) mediate the anti-apopto-
sis/pro-survival signal. Our demonstration of a signifi-
cant increase in survivin expression concomitant with
SMG lumina formation, as well as survivin protein's nu-
clear localization in presumptive ductal and proacinar
lumen-bounding cells, suggest that survivin is be a key
mediator of embryonic SMG lumen-bounding epithelial
cell survival.
Materials and Methods
Tissue Collection
Female B10A/SnSg mice, obtained from Jackson Labo-
ratories (Bar Harbor, ME), were maintained and mated
as previously described [1]; plug day = day 0 of gestation.
Pregnant females were anesthetized on days 14-18 of ges-
tation (E14-18) with methoxyflurane (metafane) and eu-
thanized by cervical dislocation. This research
conformed to the Animal Resource Institutional Review
and Ethics Committee. Embryos were dissected in cold
phosphate buffered saline (PBS) and staged according to
Theiler [18]. E14-E18 SMGs and E15-E17 lungs were col-
lected and stored at -70° C or processed for histology.
Analysis of RNA by Primer Extension
Total RNA from E14 Pseudoglandular SMGs (64 glands/
3 litters); E15 Canalicular SMGs (52 glands/3 litters) and
E17 Terminal Bud SMGs (48 glands/3 litters) were ex-
tracted as previously described [3]. Primer extension
was conducted essentially as described in Li and Altieri
[10]. A msg-PE oligonucleotide 5'-GGCTCTTTCTCTGCT
CAGTTT-3' was synthesized, gel purified and 5' end-la-
beled; a control primer was also radiolabled. For primer
extension, 40 µ g total RNA per stage was hybridized with
an excess of 5'-radiolabeled DNA primers. The resulting
end-labeled cDNA was separated on a urea-denaturing
polyacrylamide gel, visualized, and quantitated by phos-
phor image analysis with ImageQuant software. Relative
levels of survivin mRNA were tabulated as the percent
transcript level relative to that in the Pseudoglandular
Stage. Subsequent analysis was by t-test for the signifi-
cance of differences between percentages based on the
arcsin transformation; it employs a constant represent-
ing the parametric variance of a distribution of arcsin
transformations of percentages [19].
Immunohistochemistry
A rabbit polyclonal antibody was raised against a 19 aa
peptide [NH2-MGAPTLPPAW OPFLKDHRI-COOH]
representing amino acids 1-19 of the deduced human
amino acid sequence [6]. Using anti-survivin antiserum
and Western blot analysis, survivin protein (Mr ~ 16
kDa) was detected in the lysates of 3 cancer cell lines
(MO7E, HL-60, and HELA), but not in normal whole hu-
man blood cell lysates; survivin was not detected by the
control serum. The antibody was purified from the im-
mune sera by affinity chromatography on a peptide col-
umn and specificity determined by Western blot analysis
[3]. Extracts of the HL-60 were analyzed to demonstrate
antibody specificity. No band was seen in control affinity
column eluate of the prebleed serum. For immunolocal-
ization studies, embryonic SMGs and lungs were fixed in
Carnoy's fixative, processed, and immunohistochemistry
conducted as previously described [3]. Immunohisto-
chemical staining was performed using the Elite ABC kit
(Vector Laboratories, Burlingham, CA).
Acknowledgements
This research was supported by NIH grant DE 11942.
References
1. Jaskoll  T,  Melnick  M:  Submandibular  gland  morphogenesis:
stage-specific expression of TGF-α /EGF, IGF, TGF-β , TNF,
and IL-6 signal transduction in normal embryonic mice and
the phenotypic effects of TF-β 2, TGF-β 3 and EGF-R null mu-
tations. Anat Rec 1999, 256:252-268
2. Melnick M, Jaskoll T: Mouse submandibular gland morphogen-
esis: a paradigm for embryonic signal processing. Crit Rev Oral
Biol Med 2000, 11:199-215
3. Melnick M, Chen H, Zhou Y, Jaskoll T: Embryonic mouse sub-
mandibular gland morphogenesis and the TNF/TNF-R1 sig-
nal transduction pathway. Anat. Rec. 2001, 262:318-330
4. Adida C, Crotty PL, McGrath J, Berrebi D, Altieri DC: Develop-
mentally regulated expression of the novel cancer anti-apop-
tosis gene survivin in human and mouse differentiation. Am. J.
Path. 1998, 152:43-49
5. Altieri DC, Marchisio C: Survivin Apoptosis: an interloper be-
tween cell death and cell proliferation in cancer. Lab. Inv. 1999,
79:1327-1333BMC Developmental Biology (2001) 1:5 http://www.biomedcentral.com/1471-213X/1/5
6. Ambrosini G, Adida C, Altieri DC: A novel antiapoptosis gene,
survivin, expressed in cancer and lymphoma. Nat. Med. 1997,
3:917-921
7. Kobayashi K, Hatano M, Otaki M, Ogasawara T, Tokushisa T: Ex-
pression of a murine homologue of the inhibitor of apoptosis
protein is related to cell proliferation. Proc. Natl. Acad. Sci. USA
1999, 96:1457-1462
8. Ambrosini G, Adida C, Siruga G, Altieri DC: Induction of apoptosis
of  inhibition  by  survivin  gene  targeting.  J.  Biol.  Chem. 1998,
273:11177-11182
9. Uren AG, Wong L, Pakusch M, Fowler KJ, Burrows FJ, Vaux DL,
Choo KHA: Survivin and the inner centromere protein IN-
CENP show similar cell cycle localization and gene knockout
phenotype. Current Biology 2000, 10:1319-1328
10. Li F, Altieri DC: The cancer antiapoptosis mouse survivin gene:
characterization of locus and transcriptional requirements
of basal and cell cycle-dependent expression. Canc. Res. 1999,
59:3143-3151
11. Suzuki A, Hayashida M, Ito T, Kawano H, Nakano T, Miura M, Aka-
hane K, Shiraki K: Survivin initiates cell cycle entry by the com-
petitive interaction with Cdk4/p16(INK4a) and Cdk2/Cyclin
E complex activation. Oncogene 2000, 19:3225-3234
12. Suzuki A, Ito T, Kawano H, Hayashida M, Hayasaki Y, Tsutomi Y, Aka-
hane K, Nakano T, Miura M, Shiraki K: Survivin initiates procase3/
p21 complex formation as a result of ineraction with Ckd4 to
resist Fas-mediated cell death. Oncogene 2000, 19:1346-1353
13. Ten Have-Opbroek: Lung development in mouse embryos. Exp.
Lung Res. 1991, 17:111-130
14. Melnick M, Chen H, Zhou Y, Jaskoll T: Interleukin-6 signaling and
embryonic mouse submandibular salivary gland morphogen-
esis. Cells, Tissues, Organs 2001, 
15. Ito T, Shiraki K, Sugimoto K, Yamanaka T, Fujikawa K, Ito M, Takase
K, Moriyama M, Kawamo H, Hayashida M, Nakano T, Suzuki A: Sur-
vivin  promotes  cell  proliferation  in  human  hepatocellular
carcinoma. Hepatology 2000, 31:1080-1085
16. De  Moerlooze  L,  Spencer-Dene  B,  Revest  J-M,  Hajihosseini  M,
Rosewell I, Dickson C: An important role for the IIIb isoform of
fibroblast growth factor receptor 2 (FGFR2) in mesenchy-
mal-epithelial signaling during mouse organogenesis. Develop-
ment 2000, 127:483-492
17. Oheyo O, Hori Y, Yamasaki M, Harada H, Sekine K, Kato S, Itoh N:
FGF10  acts  as a major ligand  for FGF  Receptor 2 IIIb  in
mouse multiorgan development. Bioch. Bioph. Res. Comm. 2000,
277:643-649
18. Theiler K: The House Mouse. Springer-Verlag, New York. 1989, 
19. Sokal RR, Rohlf FJ: Biometry. San Francisco: W. H. Freeman, 1969,
607-608
Publish with BioMedcentral and every 
scientist can read your work free of charge
"BioMedcentral will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Paul Nurse, Director-General, Imperial Cancer Research Fund
Publish with BMc and your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours - you keep the copyright
editorial@biomedcentral.com
Submit your manuscript here:
http://www.biomedcentral.com/manuscript/
BioMedcentral.com BioMedcentral.com